Urinary retention associated with ziprasidone: a case report.
Mago
Rajnish
R
Chism
LaRissa M
LM
Pinninti
Narsimha R
NR
Certa
Kenneth
K
D014150:Antipsychotic Agents / Q000009:adverse effects*; D039721:Diagnostic and Statistical Manual of Mental Disorders; D004525:Efferent Pathways / Q000187:drug effects / Q000378:metabolism; D005260:Female; D006801:Humans; D008875:Middle Aged; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects / Q000294:innervation; D010879:Piperazines / Q000009:adverse effects*; D011618:Psychotic Disorders / Q000188:drug therapy*; D011903:Raphe Nuclei / Q000187:drug effects / Q000378:metabolism; D013844:Thiazoles / Q000009:adverse effects*; D001743:Urinary Bladder / Q000187:drug effects; D016055:Urinary Retention / Q000139:chemically induced*
D014150:Antipsychotic Agents; D010879:Piperazines; D013844:Thiazoles; C092292:ziprasidone